On 5 and 6 December 2017, Alzheimer Europe (AE) hosted its third annual Alzheimer’s Association Academy in Brussels, Belgium. The meeting was attended by 49 participants including representatives from AE member organisations, national Alzheimer associations and company. There were 14 expert speakers on the packed agenda. The two-day Academy was a highly interactive event, with lots of time for questions after each of the five sessions, which focused on:
- The role of biomarkers in the diagnosis of Alzheimer’s disease/dementia
- EU research collaboration on timely diagnosis – Opportunities for collaboration with Alzheimer’s associations
- Patient and public involvement in dementia research
- Real-world evidence in dementia research
- EU programmes and their relevance for Alzheimer’s associations
We were glad to see that two epadistas were invited to present the EPAD project.
Richard Milne from the University of Cambridge, United Kingdom, (WP8 co-leader) gave a presentation entitled “How to communicate biomarker results in an asymptomatic, MCI and dementia population? Challenges identified by the EPAD and AMYPAD projects”.
Stina Saunders from the University of Edinburgh, United Kingdom, presented the participant panel in EPAD as a model of involving research participants in research.